CURRICULUM VITAE
Brian Branchford MD
Brian Branchford MD
Associate Professor
Department of Pediatrics
Division of Hematology and Oncology - Pediatrics
Associate Investigator
Versiti Blood Research Institute
Associate Medical Director
Versiti Medical Science Institute
Department of Pediatrics
Division of Hematology and Oncology - Pediatrics
Associate Investigator
Versiti Blood Research Institute
Associate Medical Director
Versiti Medical Science Institute
OFFICE ADDRESS: |
Children’s Wisconsin - Milwaukee Hospital |
8915 W Connell Court |
Milwaukee, WI 53226 |
Email: bbranchford@mcw.edu |
EDUCATION: |
1997 - 2001 B.A., Biology, Lawrence University, Appleton |
2001 - 2005 M.D., University of Wisconsin School of Medicine and Public Health, Madison, WI |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
2005 - 2008 Pediatric Residency, Children's Hospital of Wisconsin, Milwaukee WI |
2008 - 2009 Chief Pediatric Resident, Children's Hospital of Wisconsin, Milwaukee, WI |
2009 - 2012 Hematology/Oncology/BMT, Children's Hospital Colorado, Aurora, CO |
2012 - 2013 Instructor/Fellow Pediatric Hematology, Children's Hospital Colorado, Aurora, CO |
FACULTY APPOINTMENTS: |
2013 - 2015 Clinical Instructor, Department of Pediatrics, Division of Hematology/Oncology, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado |
2015 - 2020 Assistant Professor, Department of Pediatrics, Division of Hematology/Oncology, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado |
2020 - Present Associate Medical Director, Versiti Medical Science Institute |
Associate Investigator, Versiti Blood Research Institute |
Assistant Professor, Department of Pediatrics, Division of |
Hematology/Oncology, Medical College of Wisconsin, Children's Wisconsin |
HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS: |
2008 - 2009 Chief Pediatric Resident, Children's Hospital of Wisconsin, Milwaukee WI |
2019 - 2020 Director, Thrombosis Program, University of Colorado Hemophilia and Thrombosis Center, Aurora, CO |
HOSPITAL STAFF PRIVILEGES: |
1312 - Present E 16th Ave |
2013 - 2020 Children's Hospital Colorado |
2020 - Present Children's Hospital of Wisconsin |
9000 - Present W. Wisconsin Ave. |
Milwaukee, WI 53226 |
Aurora, CO 80045 |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
Pediatrics (ABP ID #674322) | 2008 | 2018 |
Pediatric Hematology - Oncology | 2015 | None |
Licensure | Number | Issue Date | Expiration |
Licensure Wisconsin | 49760-20 | 09/19/6 | 10/31/21 |
AWARDS AND HONORS: |
2010 - 2011 American Society of Hematology, Selected for year-long Translational Research Training in Hematology (TRTH) Course |
2011 - Present International Society of Thrombosis & Hemostasis Annual Meeting, Young Investigator Award |
2011 - Present Children's Hospital Colorado Springs Poster Session, Best Poster Award |
2011 - 2019 National Institutes of Health: Loan Repayment Program |
2011 - Present American Society of Hematology Annual Meeting, Abstract Achievement Award |
2011 - Present Hemophilia/ Thrombosis Research Society Annual Meeting, Young Investigator Award |
2011 - Present Gordon Research Seminar (Hemostasis), Best Oral Presentation |
2012 - Present American Society of Hematology Annual Meeting, Abstract Achievement Award |
2013 - Present Hemophilia/Thrombosis Research Society Annual Meeting, Junior Investigator Award |
2013 - Present Hemophilia/Thrombosis Research Society Annual Meeting, Blue Ribbon Poster of Distinction |
2013 - Present Children's Hospital Colorado, Pillar Award for Outstanding Performance |
2015 - Present American Society of Hematology Annual Meeting, Abstract Achievement Award |
2019 - Present Publons, Global Peer Review Award: Top 1% in Field |
2022 - Present Jacqueline and Arlyn Frederick Award for Clinical Research |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
2011 - Present Member (International Society of Thrombosis and Haemostasis (ISTH)) |
2012 - Present Member (American Society of Hemostasis (ASH)) |
2012 - Present Member (Hemostasis and Thrombosis Research Society (HTRS)) |
EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS: |
Journal Review |
2012 - Present Manuscript Peer-Review Referee - Ad Hoc Reviewer. 131 verified reviews (Review statistics at https://publons.com/researcher/1191335/brian-branchford) |
2014 - Present Review Editor - Frontiers in Hematology, Pediatric Immunology |
2016 - 2018 Guest Associate Editor - Frontiers in Hematology, Pediatric Immunology |
LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
2012 - 2020 Physician Co-Leader, CCBD Process Improvement Group, Hospital- Associated VTE Prevention Division (Pediatric Hematology/Oncology - Center for Cancer and Blood Disorders [CCBD]), Children's Hospital Colorado, Aurora CO |
2012 - 2020 Co-Leader, Hospital-wide Multidisciplinary Group, Hospital-Associated VTE Prevention Hospital (Children's Hospital Colorado, Aurora CO) |
2019 - 2020 Member, Clinical Pathways and Measures Committee, Venous Thrombosis Diagnosis and Management, Venous Thromboembolism Prophylaxis, Anticoagulation Dosing and Monitoring |
2019 - 2020 Hematology Representative, Inpatient Handoff Document Development Team, Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora CO |
2020 Reviewer, Medical Student Research Day Poster Session, Medical College of Wisconsin, Wauwatosa WI |
2021 Pediatric Hematology/Oncology Fellowship Interviewer, Medical College of Wisconsin, Wauwatosa WI |
2021 Faculty Interviewer, Versiti Blood Research Institute and Medical College of Wisconsin, Wauwatosa WI |
2021 Judge, SAMS/MSSRP Virtual Poster Program, Medical College of Wisconsin, Wauwatosa WI |
2021 Co-Host PI, BRI Seminar Series, Versiti Blood Research Institute, Wauwatosa WI |
NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
2013 - 2020 National Physician Co-Leader, Children's Hospital Solution for Patient Safety (CHSPS) Committee for Prevention of Hospital-Acquired Conditions, Hospital-Acquired VTE Section |
2014 - Present Reviewer, Hemostasis and Thrombosis Research Society Mentored Research Awards |
2014 - Present Co-Founder and Co-Principal Investigator, Children's Hospital-Acquired Thrombosis (CHAT) clinical research consortium |
2015 Reviewer, Hemostasis and Thrombosis Research Society/American Thrombosis and Hemostasis Network Dataset Research Enrichment and ATHN Membership (DREAM) Awards |
2016 Reviewer, National Hemophilia Foundation Judith Graham Pool Award |
2017 - 2019 Member, Data Safety Monitoring Board, Prevention of Central Venous Catheter-Associated in Critically Ill, Children: A Multicenter, Phase 2aTrial: Catheter-Related Early Thromboprophylaxis with Enoxaparin (CRETE) Trial. |
2017 - Present Member, Venous thromboEmbolism Network United States (VENUS): Pediatric Thrombosis Committee |
2017 - Present Director, HTRS Board of Directors |
2018 - Present Member, Clinical Genome Resource (ClinGen) Working Group for Platelet Disorders Working Group for Thrombotic Disorders |
2019 Reviewer, Hemostasis and Thrombosis Research Society Mid-Career Research Award |
2019 Reviewer, National Hemophilia Foundation Investigator-Initiated Award |
2019 Reviewer, University of Colorado Clinical and Translational Sciences Institute: PreK Mock Review Program for K23 Awards |
2019 Reviewer, University of Colorado Clinical and Translational Sciences Institute: Child and Maternal Health Pilot Grant Program |
2019 - 2020 Reviewer, American Heart Association Innovative Project Award |
2020 Reviewer, University of Colorado Clinical and Translational Sciences Institute: Mock National Research Service Award Study Section - F32 Award |
2020 - Present Member, Hemostasis and Thrombosis Research Society Officer Nominating Committee |
2020 - Present Member, Preterm Infants Committee, Recipient Epidemiology and Donor Evaluation Study IV-Pediatric (REDS-IV-P) of NIH National Heart Lung Blood Institute, Wisconsin Hub |
INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
2014 - Present Member, ISTH Working Group for Pediatric Hospital-Acquired Venous Thromboembolism Prevention/Risk Scores |
2014 - Present Member, Scientific and Standardization Committee, ISTH Pediatric/Neonatal Hemostasis and Thrombosis |
2017 - Present Executive Committee Member (U.S. Representative), International Pediatric Thrombosis Network |
2020 - Present Member, ISTH SSC Working Group for Pediatric Thromboprophylaxis |
2020 - Present Member, Executive Steering Committee: Pediatric Duration of Therapy in Thrombosis 2: Direct Oral Anticoagulants (Kids-DOTT2: DOAC). Principal Investigator: Neil Goldenberg, MD, PhD. Johns Hopkins All Children's Hospital |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
International |
Presenter, “Which Risk Groups of Children Should Receive Prophylaxis?”, ISTH Congress, Berlin, Germany, 2017 |
National |
Presenter, “Think Tank on Epidemiology and Translational Studies in Transfusion Medicine, Hemostasis and Thrombosis in Neonatal and Pediatric Populations”, NIH-NHLBI, 2012 |
Presenter, “Rethinking New Technologies to Facilitate Pediatric and Neonatal Clinical Trials in Hemostasis, Thrombosis, and Transfusion Medicine”, NIH-NHLBI Working Group, 2012 |
Presenter, “Novel Gas6/TAM Inhibitors decrease platelet activation and thrombus formation”, Pediatric Hematology/Oncology Section Meeting, Cincinnati Children’s Hospital Medical Center, 2014 |
Presenter, “Microfluidic Technology as an Emerging Clinical Tool to Evaluate Thrombosis and Hemostasis”, National Hemophilia Foundation annual meeting, Dallas, Tx., 2015 |
Presenter, “Pediatric Hospital-Acquired VTE Risk Scores”, HTRS annual meeting Session: Pediatric VTE Prevention – Are We There Yet?, Scottsdale, AZ, 2017 |
Presenter, “The Role of GAS6-MERTK Signaling in Platelet Activation and Thrombus Formation”, Johns Hopkins Medical Institute Hematology Section Meeting, Baltimore, MD, 2018 |
Presenter, "The Role of GAS6-MERTK Signaling in Platelet Activation and Thrombus Formation"., Pediatric Hematology/Oncology Conference., Nationwide Children's Hospital: Columbus OH., 2019 |
Presenter, "Pediatric Venous Thromboembolism"., Pediatric Grand Rounds, Arnold Palmer Hospital for Children: Orlando FL., 2019 |
Presenter, "Translational Research in Pediatric Venous Thromboembolism"., Indiana Hemophilia Treatment Center, 2020 |
Presenter, "Pediatric Venous Thromboembolism", Pediatric Grand Rounds, Children's Hospital and Medical Center: Omaha NE, 2020 |
Presenter, "The Interplay of Inflammation and Thrombosis"., 6th Annual Taru Hays Hematology Symposium, Children's Hospital Colorado, 2021 |
Presenter, "Translational Research in Pediatric Hospital-Acquired Venous Thromboembolism", Aflac Research Conference, Emory University, 2022 |
Local |
Presenter, “The Role of GAS6-MERTK Signaling in Platelet Activation and Thrombus Formation”., Versiti Blood Research Institute: Milwaukee, WI., 2018 |
Presenter, Responsible Conduct of Research Conference Series. "Collaborative Research", Versiti Blood Center of Wisconsin, 2021 |
Presenter, "Thrombosis Pathogenesis and Treatment", Versiti Comprehensive Center for Blood Disorders Plasma Academy., 2022 |
EXTRAMURAL TEACHING: |
Medical Student Education |
2010 - 2020 University of Colorado School of Medicine, Small Group Leader-Blood & Lymph Pathology |
2021 Medical College of Wisconsin, Wauwatosa, WI, Small Group Leader and Clinician Specialist – Sickle Cell Case-Based Discussion for first year medical students |
Resident and Fellow Education |
2011 - 2013 Organized bi-weekly Hematology Consult Conference for fellows and attendings |
2011 - 2014 Organized monthly Coagulation Conference for fellows and attendings |
2012 - Present Supervision and teaching of residents/fellows on inpatient hematology service (6 wks/yr) |
2012 - 2020 University of Colorado Hemophilia & Thrombosis Center Clinic, Supervision of residents/fellows/advanced practice providers (1d/wk) |
2018 CHCO Pediatric Resident Academic Half-Day, Curriculum Development and Hematology Instructor |
2020 - Present Versiti Comprehensive Center for Blood Disorders ambulatory clinic (1 day/wk), Supervision of medical students/residents/fellows/advanced practice providers |
2020 CHCO Pediatric Resident Academic Half-Day, Curriculum Development and Hematology Instructor |
EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Undergraduate Students |
2018 Drishti Patel, Clinical - Child Health Research Internship Mentor, Pediatric Hospital-Acquired VTE Prevention |
2019 Tu Tran, Lab Research Mentor, Platelet Signaling in Thromboinflammation |
2022 - Present Iliana Hunsberger, Laboratory, GAS6 levels in healthy vs. inflamed children. |
2022 - Present David Sokol, Laboratory |
Medical Students |
2011 - 2014 Luke Law, Laboratory - Mentored Scholarly Activity Program Mentor, In vitro platelet activation and in vivo thrombosis models |
2013 Gilbert Acevedo, Laboratory, In vitro platelet activation & in vivo thrombosis models |
2014 - 2016 Natalie Smith, Clinical, Pediatric VTE risk factors and prevention |
2015 - 2017 Kelsey Fowlkes, Clinical, Pediatric VTE risk factors and prevention |
2016 - 2017 Michael Dittmar, Clinical - Research Mentor, Pediatric Hospital-Acquired VTE Case Detection |
2017 - 2018 Bobby Meller, Laboratory - Mentored Scholarly Activity Program Mentor, Inflammatory Mediators & Platelet Signaling in VTE |
2017 - 2021 Peter Doan, Clinical - Mentored Scholarly Activity Program Mentor, Superficial Vein Thrombosis and VTE |
2019 - Present Kailey Stiles, Clinical Research Mentor, Inflammation and VTE |
2019 - Present Taylor Harp, Clinical Research Mentor, Inflammation and VTE |
2022 - Present Aly Sonnen, Clinical Advisor |
Clinical/Research Fellows |
2015 - 2016 Michelle Loi, Clinical - Scholarship Oversight Committee Member, Altitude Effects on Pulmonary Embolism and Biomarkers of Catheter-Associated VTE in Critically Ill Children |
2015 - 2017 Jessica Knight-Perry, Clinical - Master’s Thesis Committee Member, VTE in cystic fibrosis patients
Scholarship Oversight Committee Member |
2015 - 2017 Pavel Davizon-Castillo, Laboratory
Scholarship Oversight Committee Member, Inflammation and Aging |
2017 - 2018 Holly Pacenta, Clinical - Process Improvement Project Mentor, Iron Overload in Chronic Transfusions |
2017 - 2019 Emily Rao, Clinical-Scholarship Oversight Committee Member, Clinical Research and Process Improvement Project Mentor, Pediatric Hospital-Acquired VTE |
2020 - 2022 Amanda Scheuermann, Clinical - Scholarship Oversight Committee Member, Versiti, DOAC use in children with cancer-related VTE |
2021 Alejandra Escobar Vargo, Laboratory - Scholarship Oversight Committee Member, Versiti |
Residents |
2021 - Present Adam Kidwell, Laboratory - Research Elective Supervisor |
Clinical Staff |
2013 - 2016 Beth Warren (Pediatric Hematology Instructor), Clinical, Pediatric VTE risk factors/prevention |
COMMUNITY SERVICE ACTIVITIES: |
2022 Versiti Blood Drive at St. Paul UCC Church, Erin, WI. |
ADDITIONAL TRAINING COURSES: |
2010 University of Colorado: Applications of Molecular and Cell Biology Techniques for the Clinical Investigator |
2013 - 2014 University of Colorado Denver/Anschutz Medical Campus, Center for Bioethics and Humanities: Responsible Conduct of Research Training |
2013 - 2014 Colorado Clinical and Translational Sciences Institute (CCTSI), Colorado Mentoring Training (CO-Mentor) Program: Formal training to build practical skills for successful mentoring |
2020 - 2021 Versiti and Medical College of Wisconsin: Responsible Conduct of Research |
2020 - 2021 Versiti Medical Sciences Institute: Unconscious Bias Training Program |
CONFERENCE RESPONSIBILITIES: |
2012 - 2019 CHCO Hematology/Oncology Annual Research Conference (Aspen, CO) Co-Director (2016-2019), Moderator/Discussion Leader (2014-15), Presenter (2012-2019)
|
2013 nternational Society of Thrombosis and Hemostasis (Amsterdam, Netherlands). Session Moderator and Participant – E-poster session |
2015 Pediatric Academic Society Annual Meeting (San Diego, CA) Pediatric VTE Prevention Session: Moderator and Invited Speaker
|
2017 American Society of Hematology Annual Meeting (Atlanta, GA) Abstract Reviewer, “Disorders of Coagulation or Fibrinolysis” Oral Abstract Session Moderator, “Preclinical Studies in Bleeding Disorders”
|
2022 International Society of Thrombosis and Haemostasis (London, England, UK) Abstract Reviewer, “Thrombosis in Neonates and Children, VTE Prophylaxis, VTE Epidemiology”
|
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Flood V, Gill J, Morateck P, Christopherson P, Friedman K, Haberichter S, Branchford BR, Hoffman, R, Abshire T, DiPaola J, Hoots K, Leissinger C, Lusher J, Ragni M, Shapiro A, Montgomery R. VWF exon 28 polymorphisms associated with decreased VWF:RCo/VWF:Ag ratios. Blood. 2010: 116(2): 280-286. PMID 20231421 |
2. Goldenberg N, Branchford B, Wang M, Durham J, Ray C, Manco-Johnson M. Percutaneous Mechanical and Pharmacomechanical Thrombolysis for Occlusive Deep Venous Thrombosis of the Proximal Limb in Adolescents: Findings from an Institution-Based Prospective Inception Cohort Study of Pediatric Venous Thromboembolism. J Vasc Interv Radiol 2011; 22:121-132. PMID 21216157 |
3. Cooper L, Moore C, Branchford B, Greffe B, Capocelli K, Kuder A, Mehta I, Mourani P. Successful pulmonary artery embolectomy in a patient with a saddle Wilms tumor embolus. Pediatr Blood & Cancer. 2012; 58(5):806-9. PMID 21681933 |
4. Branchford BR, Mourani P, Bajaj L, Manco-Johnson M, Wang M, Goldenberg N. Risk Factors for the Development of In-Hospital Venous Thromboembolism in Children: A Case-Control Study Employing Diagnostic Validation. Haematologica. 2012; 97(4):509-15. PMID 22104422 |
5. Branchford BR, Gibson E, Manco-Johnson M, Goldenberg N. Sensitivity of discharge diagnosis ICD-9 codes for pediatric venous thromboembolism is greater than specificity, but still suboptimal for clinical research. Thromb Res. 2012; 129(5):662-3. PMID 22104422 |
6. Liang X, Branchford B, Greffe B, McGavran L, Carstens B, Meltesen L, Albano E, Quinones R, Cook B, Graham DK. Alk-Positive Extranodal Anaplastic Large Cell Lymphoma with Concurrent MYC Rearrangement in a Pediatric Patient. J Pediatr Hematol Oncol. 2013; 35(5):e209-13, PMID 23619105 |
7. Flood VH, Friedman KD, Gill JC, Haberichter SL, Christopherson PA, Branchford BR, Hoffman RG, Abshire TC, Dunn AL, Di Paola JA, Hoots WK, Brown DL, Leissinger C, Lusher JM, Ragni MV, Shapiro AD, Montgomery RR. No increase in bleeding identified in type 1 VWD subjects with D1472H Sequence Variation. Blood. 2013; 121(18)3742-4. PMID 23520336 |
8. Zhang W, McIver A, Stashko MA, DeRyckere D, Branchford BR, Hunter D, Kireev D, Miley MJ, Norris-Drouin J, Stewart WM, Lee M, Sather S, Zhou Y, Di Paola JA, Machius M, Janzen WP, Earp HS, Graham DK, Frye SV, Wang X. Discovery of Mer-specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis. J Med Chem. 2013; 56(23): 9693-700. PMID 23520336 |
9. Branchford BR, Ruegg K, Vilalobos-Menuey, Jacobson L, Di Paola J, Manco-Johnson M. FVIII/VWF ratio is not a reliable predictor of VWD in children. Pediatr Blood Cancer. 2014;61(5): 936-9 PMID 24281894 |
10. Atchison CM, Arlikar S, Amankwah E, Ayala I, Barrett L, Branchford BR, Streiff M, Takemoto C, Goldenberg NA. Development of a New Risk Score for Hospital-Associated Venous Thromboembolism in Non-Critically-Ill Children: Findings from a Large Single-Institutional Case-Control Study. J. Pediatr. 2014; 165(4): 793-8. PMID 25064163 |
11. Amankwah E, Atchison CM, Arlikar S, Ayala I, Barrett L, Branchford BR, Streiff M, Takemoto C, Goldenberg NA. Risk Factors for Hospital-Associated Venous Thromboembolism in the Neonatal Intensive Care Unit. Thrombosis Research. 2014; 134(2):305-9. PMID 24953982 |
12. Arlikar SJ, Atchison CM, Amankwah EK, Ayala IA, Barrett LA, Branchford BR, Streiff M, Takemoto CM, Goldenberg NA. Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery. Thrombosis Research. 2015; 136(4): 717-22. PMID 25979250 |
13. Mahajerin A, Branchford BR, Amankwah EK, Raffini L, Chalmers E, van Ommen CH, Goldenberg NA. Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk assessment models. Haematologica. 2015; 100(8): 1045-50. PMID 26001789 |
14. Dittmar M, Smith N, Warren B, Clark B, Wathen B, Hammett K, Reiter P, Hilden J, Goldenberg NA, Branchford B. Improved sensitivity and specificity of pediatric hospital-acquired venous thromboembolism case identification by radiographic designation. Thrombosis Research. 2017; 154: 93-95. PMID 2845607 |
15. Maloney JP, Branchford BR, Brodsky GL, Cosmic MS, Calabrese DW, Aquilante CL, Maloney KW, Gonzalez JR, Zhang W, Morequ KL, Wiggings KL, Smith NL, Broeckel U, Di Paola J. The ENTPD1 promoter polymorphism 860A>G (rs3814159) is associated with increased gene transcription, protein expression, CD39/NTPDase1 enzymatic activity, and thromboembolism risk. FASEB J. 2017. PMID 28302652 |
16. Kastelowitz N, Tamura R, Onasoga A, Stalker T, White O, Brown P, Brodsky G, Brass L, Branchford B, Di Paola J, Yin H. Peptides derived from MARCKS block coagulation complex assembly on phosphatidylserine. Sci Rep 2017 Jun 27;7(1): 4275. PMID: 28655899; PMCID: PMC5487340 |
17. Knight-Perry J, Branchford BR, Thornhill D, Martiniano SL, Sagel SD, Wang M. Venous Thromboembolism in Children with Cystic Fibrosis: Retrospective Incidence and Intrapopulation Risk Factors. Thromb Res. 2017 Oct; 158:161-166. PMID: 28934665 |
18. Atchison, CM, Amankwah E, Wilhelm J, Arlikar S, Branchford BR, Stock A, Streiff M, Takemoto C, Ayala I, Everett A, Stapleton G, Jacobs J, Goldenberg NA. Risk Factors for Hospital-Associated Venous Thromboembolism in Critically-Ill Children Following Cardiothoracic Surgery or Therapeutic Cardiac Catheterisation. Cardiol in Young. 2017 Nov 8;1-9. PMID: 29115202 |
19. Branchford BR, Mahajerin A, Raffini L, Chalmers E, van Ommen CH, Chan AKC, Goldenberg NA; Recommendations for standardized risk factor definitions in pediatric hospital-acquired venous thromboembolism to inform future prevention trials: Communication from the Subcommittee on Pediatric/Neonatal Hemostasis and Thrombosis of the International Society of Thrombosis and Hemostasis. J Thromb Haemost. 2017 Nov; 15(11):2274-2278. PMID: 29027741 |
20. Jaffray J, Mahajerin A, Young G, Goldenberg N, Ji L, Sposto R, Stillings A, Krava E, Branchford B. A multi-institutional registry of pediatric hospital acquired thrombosis cases: The Children's Hospital-Acquired Thrombosis (CHAT) Project. Thromb Res. 2018 Jan;161:6-72. PMID: 29207321 |
21. Newall F, Branchford B, Male C. Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues. J Throm Haemost. 2018 Feb; 16(2): 196-208. PMID: 29316202 |
22. Branchford BR, Betensky M, Goldenberg NA. Pediatric issues in thrombosis and hemostasis: The how and why of venous thromboembolism risk stratification in hospitalized children. Thromb Res. 2018 Dec; 172:190-193. PMID: 29472108 |
23. Branchford BR, Stalker TJ, Law L, Acevedo G, Sather S, Brzezinski C, Wilson KM, Minson K, Lee-Sherick AB, Davizon-Castillo P, Ng C, Zhang W, Neeves KB, Lentz SR, Wang X, Frye SV, Earp HS, DeRyckere D, Brass LF, Graham DK, Di Paola JA. The small molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. J Thromb Haemost. 2018 Feb;16(2): 352-363. PMID: 29045015 |
24. *Commentary in J Thromb Haemost: Cosemans JMEM. At the MERcy of platelet primers. J Thromb Haemost. 2018 Feb;16(2): 349-351. |
25. Law L, Graham D, Di Paola J, Branchford BR. GAS6/TAM pathway signaling in hemostasis and thrombosis. Front Med 2018 May 9; 5:137. PMID: 29868590. PMCID: PMC5954114 |
26. Branchford BR and Carpenter, S. The role of inflammation in venous thrombosis. Front Pediatr. 2018 May 23;6: 142. PMID: 29876337. PMCID: 5974100 |
27. Lyren A, Coffey M, Shepherd M, Lashutka N, Muething S, the SPS Leadership Group. We will not compete on safety: How children's hospitals have come together to hasten harm reduction. Jt. Comm J Qual Patient Saf. 2018 Jul;44(7):377-388. PMID: 30008350 |
28. Stoffman JM, Andersson NG, Branchford B, Batt K, D'Orion R, Escuriola Ettingshausen C, Hart DP, Jiminez-Yuste V, Kavakli K, Nogami K, Ramirez C, Wu R. Common themes and challenges in hemophilia care: A multinational perspective. Hematology. 2019; 24(1): 39-48. PMID: 30073913 |
29. Heizer JW, Shardt TQ, Murphy ME, Branchford BR. Unfractionated heparin dosing requirements in the presence of inflammation during the first six months of life. Thromb Res. 2019 May; 177:17-22. PMID: 30844684 |
30. Majtan T, Park I, Cox A, Branchford BR, di Paola J, Bublil E, Kraus JP. Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine restricted diet or enzyme replacement therapy. FASEB J. 2019 Nov; 33(11): 12477-12486. PMID: 31450979 |
31. Mahajerin A, Jaffray J, Branchford B, Stilings A, Krava E, Young G, Goldenberg N, Faustino V. Comparative validation study of risk assessment models for pediatric hospital-acquired venous thromboembolism. J Thromb Haemost. 2019 Dec. PMID: 31808292 |
32. Goldenberg NA, Branchford BR. Commentary: Phase 3 pediatric anticoagulant era. Blood. 2020 Feb; 135(7):459-60. PMID:32197268 |
33. *Commentary on Brandao LR, et al. Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. Blood. 2019 Dec 5: 135(7): 491-504. PMID:31805182 |
34. Padhye K, El-Hawary R, Price V, Stevens S, Branchford B, Kulkarni K. Development of a perioperative venous thromboembolism prophylaxis algorithm for pediatric orthopedic surgical patients. Pediatr Hematol Oncol. 2020 Mar;37(2):109-118. PMID: 31868065 |
35. Perez Botero J, Lee K, Branchford BR, Bray PF, Freson K, Lambert MP, Luo M, Mohan S, Ross JE, Bergmeier W, Di Paola J; Glanzmann Thrombasthenia: genetic basis and clinical correlates. ClinGen Platelet Disorder Variant Curation Expert Panel. Haematologica. 2020 Apr 5. 105(4):888-894. PMID: 32139434 |
36. Loi M, Branchford B, Kim J, Self C, Nuss R. COVID-19 Anticoagulation Recommendations in Children. Pediatr Blood Cancer. 2020 Sep;67(9):28485. PMID 32558124 |
37. Good RJ, Levin M, Feder S, Loi MM, Kim JS, Branchford BR, Czaja AS, Carpenter TC. Accuracy of bedside ultrasound femoral vein diameter by PICU providers. Pediatr Crit Care Med. 2020 Dec;21(12):e1148-e1151. PMID 32639474 |
38. Park I, Johnson LK, Haefner K, Cox A, Branchford BR, Cavasin M, di Paola J, Bublil E and Majtan T. Hypermethioninemia leads to increased mortality and coagulopathy in a transgenic I278T mouse model of homocystinuria. Biomedicines. 2020 Jul 24;8(8):244. PMID 32722248 |
39. Jaffray J, Branchford B, Goldenberg N, Malvar J, Croteau SE, Silvey M, Fargo JH, Cooper JD, Bakeer N, Sposto R, Ji L, Zakai NA, Faustino EVS, Stillings A, Krava E, Young G, Mahajerin A. Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the CHAT Consortium. J Pediatr. 2021 Jan;228:252-259. PMID 32920105 |
40. MacNevin W, Padhye K, Price V, El-Hawary R, Branchford BR, Stevens S, Kulkarni K. Optimizing pharmacologic thromboprophylaxis use in pediatric orthopedic surgical patients through implementation of a perioperative venous thromboembolism risk screening tool. Pediatr Blood Cancer. 2021 Feb;68(2):e28803. PMID 33219749 |
41. Ross JE, Zhang BM, Lee K, Mohan S, Branchford BR, Bray P, Dugan SN, Freson K, Heller PG, Kahr WHA, Lambert MP, Luchtman-Jones L, Luo M, Perez-Botero J, Rondina MT, Ryan G, Westbury S, Bergmeier W, Di Paola J. Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel. Blood Adv. 2021 Jan 26;5(2):414-431. PMID 33496739 |
42. Doan P, Cox A, Rao E, Branchford B. Temporal and anatomic relationship between superficial and deep vein thrombosis in children. Thromb Res. 2021 Apr;200:30-33. PMID 33529870 |
43. van Ommen CH, Albisetti M, Bhatt M, Bonduel M, Branchford B, Chalmers E, Chan A, Holzhauer S, Monagle P, Nowak-Gottl U, Revel-Vilk, Sirachainan, Male C for the Subcommittee on Pediatric and Neonatal Hemostasis and Thrombosis. International Pediatric Thrombosis Network to advance pediatric thrombosis research: communication from the Neonatal and Pediatric SSC of the ISTH. J Thromb Haemost. 2021 Apr;19(4):1123-1129. PMID 33792176 |
44. Hart DP, Branchford BR, Hendry S, Ledniczky, Sidonio RF, Negrier C, Kim M, Rice M, Minshall M, Arce C, Prince S, Kelleher M, Lee S. Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study. Orphanet J Rare Dis. 2021 Apr 28;16(1):189. PMID: 33910590 |
45. Ng CJ, Spomer N, Shearer R, LeBlanc A, Funk S, Manco-Johnson M, Branchford B, Warren B, Buckner TW, Moyer G, Wang M, Gibson E, Mashburn C. Improvements in Communication and Coordination of Care in a Hemophilia Treatment Center. Acta Haematol. 2021 Apr 29:1-6. PMID: 33915533 |
46. Warren BB, Chan A, Manco-Johnson M, Branchford BR, Buckner TW, Moyer G, Gibson E, Thornhill D, Wang M, Ng C. Emicizumab Initiation and Bleeding Outcomes in Hemophilia A Patients with and without Inhibitors, a Single-Center Report. Res Pract Thromb Haemost. 2021 Aug 3:5(5): e12571. PMID: 34377887 |
47. Jaffray J, Mahajerin A, Branchford B, Nguyen ATH, Faustino EVS, Silvey M, Croteau SE, Fargo JH, Cooper JD, Bakeer N, Zakai NA, Stillings A, Krava E, Amankwah E, Young G, Goldenberg NA. A New Risk Assessment Model for Hospital-Acquired Venous Thromboembolism in Critically Ill Children: A Report from the CHAT Consortium. Pediatr Crit Care Med. 2022 Jan 1;(23):e1-e9. PMID: 34406168 |
48. Jaffray J, Baumann-Kreuziger L, Branchford B, Wee CP, Faustino EVS, Zakai N, Croteau SE, Silvey M, Fargo JH, Cooper JD, Bakeer N, Stillings A, Krava E, Young G, Goldenberg NA. Symptomatic pulmonary embolus after catheter removal in children with catheter-related thrombosis: A report from the CHAT Consortium. J Thromb Haemost. 2022 Jan;20(1): 133-137. PMID:34523749 |
49. Jones WL, Ramos CR, Banerjee A, Moore EE, Hansen KC, Coleman JR, Kellher M, Neeves KB, Silliman CC, Di Paola J, Branchford BR. Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and deceases clot strength. Platelets. 2022 [Accepted, In Press] |
50. Scheuermann A, Liegl M, Simpson P, Branchford B, Malec M. Safety and Efficacy of Direct Oral Anticoagulants for Treatment of Venous Thromboembolism in Pediatric Oncology Patients. J Ped Hematol Oncol. 2022 [Accepted, In Press]. |
Books, Chapters, and Reviews |
1. Branchford BR, Goldenberg N. "Pediatric Venous Thromboembolism." In: Elzouki (ed), Textbook of Clinical Pediatrics, 2nd ed. Lippincott, Williams, and Wilkins; Philadelphia, 2011 |
2. Branchford BR, Raffini L. "Prophylaxis of Pediatric Thrombosis." In: Manco-Johnson and Goldenberg (ed), Pediatric Thrombotic Disorders, 1st ed. Cambridge Univ. Press; New York, 2014 |
3. Branchford B, DiPaola J. "Analysis of the Bleeding Child." In: Orkin, Nathan, Ginsburg, Look, Fisher, & Lux (ed), Nathan and Oski's Hematology of Infancy and Childhood, 8th ed. Saunders Elsevier; Philadelphia, 2014 |
4. Bernard T, Poisson S, Branchford BR, Nowak-Gottl U. "Coagulation Disorders and Cerebrovascular Disease in Children." In: Swaiman, Ashwal, Ferriero, Schor (ed) Swaiman's Pediatric Neurology: Principles and Practice, 6th ed. Saunders Elsevier; Philadelphia, 2016 |
5. Mahajerin A, Jaffray J, Branchford B. "Prevalence and Risk Factors of Adolescent Venous Thromboembolism" in: Srivaths (ed) Hematology in the Adolescent Female, 1st ed. Springer Nature; New York, 2020 |
6. Branchford BR, Flood VH. "Bleeding and Thrombosis." In: Kleigman, St. Geme, Blum, Shah, Tasker, Wilson (ed) Nelson Textbook of Pediatrics, 21st ed. Elsevier; Philadelphia, 2020 |
7. Branchford BR, Flood VH. "Bleeding and Thrombosis" In: Kliegman, Toth, Bordini, Basel (ed) Pediatric Symptom-Based Diagnosis: Common Diseases and their Mimics. 2nd ed. Elsevier; Philadelphia, 2022 |
Editorials, Letters To Editor, Other |
1. Branchford BR, Di Paola J. Making a diagnosis of von Willebrand Disease. American Society of Hematology Education Program Book, 2012; 2012:161-7. PMID: 23233576 |
2. Branchford BR, Monahan PE, Di Paola J. New developments in treatment of pediatric hemophilia and bleeding disorders. Curr Opin Pediatr. 2013; 25(1):23-30. PMID: 23274430 |
3. Branchford B. Clinical and financial impact of HACs: a commentary on clinical and financial costs of hospital-acquired conditions. Transl Pediatr. 2015; 4(4):331-3. PMID 26835397 |
4. Branchford BR, Ng CJ, Neeves KB, Di Paola J. Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis. Thrombosis Research. 2015; 136(1): 13-9. PMID: 26014643 |
5. Branchford BR, Jaffray J, Mahajerin A. Editorial: Pediatric Venous Thromboembolism. Front Pediatr. 2018; 6: 269. PMID: 30320050. PMCID: PMC6170657 |
6. Branchford BR, Neeves K. New insights into platelet dysfunction in Kawasaki Disease using a microfluidic model of thrombosis. J Pediatr. 2020 Aug 11:S0022-3476(20)30998-7. PMID 32795474 |
Abstracts |
1. Friedman K, Bellissimo D, Abshire T, DiPaola J, Hoots W, Lessinger C, Lusher J, Ragni M, Shapiro A, Lillicrap D, Goodeve A, Peake I, Montgomery R. "Common VWF Haplotypes in normal African-Americans and Caucasians recruited into the ZPMCB-VWD and their impact on VWF laboratory testing." Blood. 2007; 110(11) [Abstract 714]. 2007 American Society of Hematology Annual Meeting: Atlanta, GA |
2. Branchford B, Sather S, Brodsky G, White-Adams T, DeRyckere D, Neeves K, Graham D, DiPaola J. "A Novel Splice Variant of the Mer receptor tyrosine kinase functions as an inhibitor of the Gas6/TAM signaling pathway and decreases platelet activation responses." J Thromb Haemost. 2011: 9(s2). 2011 International Society of Thrombosis and Hemostasis Scientific Congress: Kyoto, Japan |
3. Branchford B, Sather S, Brodsky G, White-Adams T, DeRyckere D, Neeves K, Graham D, DiPaola J. "iMer Blocks Phosphorylation of the αIIbβ3 Integrin, Decreasing Platelet Activation Responses and Protecting Mice From Arterial Thrombosis." Blood. 2011; 118 (11). 2011 American Society of Hematology Annual Meeting: San Diego, CA |
4. Branchford B, Law L, Sather S, Brodsky G, White-Adams T, DeRyckere D, Neeves K, Graham D, DiPaola J. "A novel Gas6/TAM signaling pathway inhibitor decreases platelet activation and arterial thrombosis." 2012 Gordon Conference-Hemostasis: Waterville Valley, NH |
5. Branchford BR, Ramos C, Moore E, Jones W, Silliman C, Banerjee A, Di Paola J. "Human Apolipoprotein A-1 decreases platelet activation responses & protects mice from arterial thrombosis." Haemophilia. 2013; 19(s5). 2013 Hemostasis and Thrombosis Research Society Annual Meeting: Charlotte, NC |
6. Jaffray J, Branchford BR, Mahajerin A, Smith N, Goldenberg N, Young G. "Children's Hospital-Acquired Thrombosis Database (CHAT): A Multi-institutional REDCap-Based Database for Prospective Identification of Independent Risk Factors." Haemophilia. 2015; 21, e264-5. 2015 Hemostasis and Thrombosis Research Society Annual Meeting: New Orleans, LA |
7. Branchford BR, Jaffray J, Mahajerin A, Goldenberg N, Young G. "Children's Hospital-Acquired Thrombosis Database (CHAT): A Multi-institutional Database for Prospective Identification of Independent Risk Factors." 2015 International Society of Thrombosis and Hemostasis Scientific Congress: Toronto, ON, CAN |
8. Branchford B, Jaffray J, Mahajerin A. "Children's Hospital-Acquired Thrombosis Registry (CHAT): A Multi-Institutional Database for Prospective Identification of Independent Risk Factors" Pediatr Blood Cancer. 2016; 63(S1):15. 2016 American Society of Pediatric Hematology/Oncology Annual Meeting, Minneapolis, MN |
9. Doan P, Cox A, Southard E, Clark B, Wathen B, Hammett K, Branchford B. Temporal and Anatomic Relationship Between Superficial and Deep Vein Thromboses in Hospitalized Children. 2018 Thrombosis and Hemostasis Summit of North America, San Diego, CA |
10. Southard E, Cox A, Clark B, Wathen B, Hammett K, Hilden J, Branchford B. Validation of Institutional Clinical Care Guidelines in Predicting Risk of Hospital-Acquired Venous Thromboembolism in an Academic Children's Hospital. 2018 Thrombosis and Hemostasis Summit of North America, San Diego, CA |
11. Branchford B, Cox A, Walker F, Davizon-Castillo P, Ashworth K, Meller R, Di Paola J. GAS6/MERTK-driven platelet activation in thromboinflammation. 2018 Gordon Research Conference - Hemostasis: Waterville Valley, NH |
12. Manco-Johnson M, Thornhill D, Wang M, Boulden Warren B, Ng C, Branchford B, Di Paola J, Ruegg K, Baird C, Jacobson L, Kamyab Hesari N, Smith T. Predictors of Recurrence and Post Thrombotic Syndrome Following Lower Extremity Deep Vein Thrombosis in Children and Adolescents: PTS Risk Reduction Using Thrombolysis as Initial Therapy. 2019 International Society of Thrombosis and Haemostasis Scientific Congress: Melbourne, AU |
13. Mahajerin A, Jaffray J, Stillings A, Krava E, Malvar J, Ji L, Sposto R, Fargo J, Cooper J, Croteau S, Silvey M, Bakeer N, Jalali A, Lonsdale H, Ahumada L, Zakai N, Faustino EV, Goldenberg N, Young G, Branchford B. The Children's Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine Learning. 2019 American Society of Hematology annual meeting: Orlando, FL |
14. Jaffray J, Baumann Kreuziger L, Branchford B, Mahajerin A, Phei Wee C, Faustino EVS, Zakai NA, Croteau SE, Silvey M, Fargo JH, Cooper JD, Bakeer N, Stillings A, Krava E, Young G, Goldenberg NA. Pulmonary Embolus after Catheter Removal in Children with Central Venous Catheter Related Venous Thromboembolism: A Report from the CHAT Consortium 2019 American Society of Hematology annual meeting (Virtual) |
15. Stephens E, Nguyen ATH, Jaffray J, Branchford B, Amankwah E, Goldenberg NA, Faustino EV, Zakai NA, Stillings A, Krava E, Young G, Fargo J. Risk of Venous Thromboembolism in Pediatric Hospitalized Patients Undergoing Non-Cardiac Surgery: A Report from the CHAT Consortium 2021 Hemostasis and Thrombosis Research Society annual meeting (Virtual) |
16. Jaffray J, Mahajerin A, Branchford B, Smith N, Goldenberg N, Young G. Children's Hospital-Acquired Thrombosis Database (CHAT): A Multi-Institutional Database for Prospective Identification of Independent Risk Factors, Haemophilia. 21, e264-e265. 2015 Hemophilia and Thrombosis Research Society Annual Meeting: New Orleans, LA |
17. Branchford B, Jaffray J, Mahajerin A, Goldenberg N, Young, G. Children's Hospital-Acquired Thrombosis Database (CHAT): A Multi-Institutional Database for Prospective Identification of Independent Risk Factors, J Thromb Haemost. 13:154. 2015 International Society of Haemostasis & Thrombosis Scientific Congress. Toronto, ON, CAN |
18. Mahajerin A, Branchford B, Jaffray J, Vasquez B, Stillings A, Smith N, Goldenberg N, Young G. Children's Hospital-Acquired Thrombosis Database (CHAT): A Multi-Institutional Database for Prospective Identification of Independent Risk Factors Blood. 126:1111. 2015 American Society of Hematology Annual Meeting: Orlando, FL |
19. Mahajerin A, Jaffray J, Vasquez B, Sposto R, Branchford B. Patterns of thrombophilia testing in pediatrics: A report from the Children's Hospital-Acquired Thrombosis (CHAT) Registry. 2016 Thrombosis and Hemostasis Summit of North America: Chicago, IL |
20. Branchford B, Jaffray J, Mahajerin A. Children's Hospital-Acquired thrombosis database (CHAT): A multi-institutional database for prospective identification of independent pediatric VTE risk factors. Pediatr Blood Cancer. 63(S1):15. 2016 American Society of Pediatric Hematology/Oncology Annual meeting: Minneapolis, MN |
21. Jaffray J, Branchford B, Vasquez B, Stillings A, Smith N, Young G, Mahajerin A. Central venous catheters and pediatric thromboembolism, a report from the children's hospital acquired thrombosis (CHAT) Registry. J Thromb Haemost. 14(S1): 90. 2016 International Society of Haemostasis & Thrombosis Scientific Congress: Montpelier, France |
22. Mahajerin A, Jaffray J, Vasquez B, Goldenberg N, Young G, Branchford B. Children's Hospital-Acquired Thrombosis (CHAT) Registry: A Multi-Institutional Registry for Prospective Identification of Independent Risk Factors. Blood. 128:2597. 2016 American Society of Hematology Annual Meeting: San Diego, CA |
23. Knight-Perry J, Towler E, Payan M, Branchford BR, Martiniano S, Sagel SD, Wang M. Venous Thromboembolism in Pediatric Cystic Fibrosis. Blood. 128:3808. 2016 American Society of Hematology Annual Meeting: San Diego, CA |
24. Ashworth K, Davizon-Castillo P, Johnson L, Branchford B, Bark D, Di Paola J. Platelet alpha-granule deficiency protects local and distal organs in intestinal ischemia reperfusion injury. Research and Practice in Thrombosis and Haemostasis. 1: 326. 2017 International Society of Thrombosis and Haemostasis Scientific Congress: Berlin, Germany |
25. Silvey M, Branchford BR, Krava E, Jaffray J, Mahajerin A, Carpenter S. Central venous access-associated thrombosis in congenital heart disease: A preliminary analysis of the Children's Hospital-Acquired Thrombosis (CHAT) database. Research and Practice in Thrombosis and Haemostasis. 1: 1191-1192. 2017 International Society of Thrombosis and Haemostasis Scientific Congress: Berlin, Germany |
26. Mahajerin A, Jaffray J, Branchford B, Vasquez B, Sposto R. Patterns of thrombophilia testing in pediatric thrombosis patients: A report from the Children's Hospital-Acquired Thrombosis (CHAT) Database. 2017 Thrombosis and Hemostasis Summit of North America: San Diego, CA |
27. Schardt T, Thornhill D, Branchford B. Comparison of Actual Body Weight, Ideal Body Weight, and Adjusted Body Weight with therapeutic enoxaparin dosing in morbidly obese pediatric patients. 2017 Hemostasis and Thrombosis Research Society Annual Meeting: New Orleans, LA |
28. Ross J, Lee K, Branchford B, Bray P, Dugan S, Freson K, Heller P, Johnson A, Kahr W, Lambert M, Lentaigne C, Luo M, Mohan S, Mumford A, Perez-Botero J, Rondina M, Ryan G, Telling L, Westbury S, Zhang B, Bergmeier W, Di Paola J. Specifications of the ACMG/AMP Variant Curation Guidelines for the Analysis of ITGA2B/ITGB3 Sequence Variants: Recommendations by GlinGen's Platelet Disorders Expert Panel. 2019 Curating the Clinical Genome Conference: Washington, D.C. |
29. Manco-Johnson M, Jones K, O'Neil P, Wang M, Boulden Warren B, Davizon-Castillo P, Ng C, Branchford B, Walker F, Smith J, Kamyab Hesari N, Gao B, Di Paola J. Enriched Variants of Coagulation, Platelet, and Related Genes are Common in Adolescents with Idiopathic Occlusive Proximal Deep Vein Thrombosis. 2019 International Society of Thrombosis and Haemostasis Scientific Congress: Melbourne, AU |
30. Manco-Johnson M, Wang M, Boulden Warren B, Buckner T, Moyer G, Jacobson L, Ruegg K, Ng C, Branchford B, Di Paola J. Emicizumab Improves Factor X Activation and Thrombin Generation Similar to Mild Hemophilia in Persons with Hemophilia A and Inhibitors. 2019 International Society of Thrombosis and Haemostasis Scientific Congress: Melbourne, AU |
31. van Ommen CH, Albisetti M, Bhatt M, Bonduel M, Branchford B, Chalmers E, Chan A, Holzhauer S. Male C. Monagle P. Nowak-Gottl U., Revel-Vilk S. International Pediatric Thrombosis Network: Advancing the field of pediatric Thrombosis 2019 International Society of Thrombosis and Haemostasis Scientific Congress: Melbourne, AU |
32. Arce C, Branchford B, Hart D, Hendry S, Kelleher M, Kim M, Ledniczky R, Lee M, Lee S, Minshall M, Negrier C, Prince S, Rice M, Sidonio R. Optimizing language for effective communication of gene therapy concepts: a qualitative study. 2019 National Hemophilia Foundation annual meeting: Anaheim, CA |
33. Jaffray J, Mahajerin A, Branchford B, Nguyen AY, Amankwah E, Silvey M, Croteau S, Cooper J, Fargo J, Bakeer N, Stillings A, Krava E, Faustino V, Zakai NA, Young G, Goldenberg N. Assessing Venous Thromboembolism Risk in Critically-Ill Children: A Report from the Children's Hospital-Acquired Thrombosis (CHAT) Consortium 2019 American Society of Hematology annual meeting: Orlando, FL |
34. Stiles K, Harp T, Cox A, Branchford B. Association Between Inflammation and Hospital-Acquired Venous Thrombosis in Pediatric Patients: A Report from the CHAT Registry. 2020 American College of Osteopathic Physicians Spring Conference (Virtual). |
35. MacNevin W, Padhye K, Price V, El-Hawary R, Branchford BR, Stevens S, Kulkarni K. Validation and Impact of a Perioperative Venous Thromboembolism Prophylaxis Algorithm for Pediatric Orthopedic Surgical Patients. (Abstract PB1281) 2020 International Society of Thrombosis and Haemostasis Scientific Congress (Virtual) |
36. Warren BB, Thornhill D, Smith J, Shearer R, Moyer G, Fox L, O'Connell M, Horton R, Funk S, Chan A, Gibson E, Ng C, Buckner TW, Branchford B Manco-Johnson MJ, Wang M. Emicizumab, beyond Annualized Bleeding Rates: Real World Joint Health and Physical Activity Data. (Abstract PB1161) 2020 International Society of Thrombosis and Haemostasis Congress (Virtual) |
37. Moyer G, Warren BB, Jacobson L, Baird CH, Thornhill D, Smith J, Ng C, Buckner TW, Branchford B, Wang M, Manco-Johnson MJ. Emicizumab, beyond Annualized Bleeding Rates: Do Laboratory Assays Help Predict Emicizumab Effects? (Abstract PB1164) 2020 International Society of Thrombosis and Haemostasis Congress (Virtual) |
38. Warren BB, Taylor J, Branchford B, Ng C, Ambruso D, Briones N, Tran A, Jacobson L, Thornhill D, Moyer G, Norton K, Buckner TW, Wang M, Manco-Johnson MJ. Emicizumab, beyond Annualized Bleeding Rates: How Does Emicizumab Affect Bone Biomarkers? (Abstract PB1165) 2020 International Society of Thrombosis and Haemostasis Congress (Virtual) |
39. Buckner TW, Rapacchietta O, Hill D, Thornhill D, Smith J, Shearer R, Ng C, Branchford B, Moyer G, Manco-Johnson MJ, Wang M. Improved Prophylaxis Adherence After Switching to Emicizumab: Real World Data from a Single Center. (Abstract PB0937) 2020 International Society of Thrombosis and Haemostasis Congress (Virtual) |
40. van Ommen CH, Albisetti M, Bhatt M, Bonduel M, Bordbar M, Branchford B, Chalmers E, Chan A, Holzhauer S, Jaffray J, Male C, Monagle P, Nowak-Gottl U, Raffini L, Revel-Vilk S, Sirachainan N, IPTN Consortium. The Throm-PED Registry: The Cornerstone of the International Pediatric Thrombosis Network. (Abstract PB1289) |
41. 2020 International Society of Thrombosis and Haemostasis Congress (Virtual) |
42. Chan A, Warren BB, Ng C, Buckner TW, Moyer G, Furton L, Branchford B, Manco-Johnson M, Wang M. Influence of Emicizumab on Patient Lifestyle at the University of Colorado.2020 World Federation of Hemophilia Conference (Virtual) |
43. Springborn S, Schulte M, Kipp M, Ghosh S, Rothlin C, Branchford B. Prothrombotic Phenotype of a Protein S Mutant Lacking Anticoagulant Activity (Abstract 2098). 2021 American Society of Hematology Annual Meeting, Atlanta, GA, USA |
